The extracellular matrix is believed to influence cellular growth through a complex set of interactions between the matrix and the cytoskeleton. Tumor cells have escaped the adhesion requirement for growth and their inability to respond to cues from the matrix is thought to contribute to their transformed phenotype. Integrin receptors are believed to transduce signals from the matrix and these signaling pathways converge with growth factor pathways in focal adhesion structures. The hypothesis to be tested in this grant is that the polymerization of fibronectin affects the nature of cell-matrix contacts and changes signaling pathways within the cell which affect cell growth. Preliminary data on human fibroblast cells indicate that fibronectin polymerization occurs in focal adhesion areas and is up-regulated by the serum mitogen, LPA through a signaling pathway regulated by the cytoplasmic region of the beta1 integrin. Our data also indicate that the matrix assembly domain of fibronectin binds to specific receptors in focal adhesion sites, affects focal adhesion structure and inhibits cell growth. Adhesion to extracellular matrix is known to be a requirement for cell cycle progression, however nothing is known about the relationship of the process of fibronectin polymerization to cell growth. In this application, we propose to recreate the steps of matrix assembly using recombinant proteins containing regions of fibronectin which interact during the polymerization of fibronectin, and then evaluate the effect of these steps on focal adhesion structure and cell cycle progression. Focal adhesion structure will be characterized morphologically by immunostaining and biochemically by comparing the phosphorylation patterns of the focal adhesion proteins FAK, paxillin and tensin. The effect of different steps in matrix assembly on cell cycle progression will be monitored by Northern analysis of marker genes for various stages of G1. The expression of cyclins as will as their effector proteins will be measured by Western blotting. Chemical cross-linking studies will be done to identify the receptor which binds to the matrix assembly domain of fibronectin. beta1 null cells will be transfected with an lL-2 beta1 chimeric receptor containing only the cytoplasmic domain, to define the molecular basis for the beta1-dependent binding of the matrix assembly domain to the cell surface. These studies will define a role for the polymerization of fibronectin in the regulation of signaling pathways which affect cell growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA069612-03
Application #
2871883
Study Section
Special Emphasis Panel (ZRG2-ET-2 (01))
Program Officer
Mohla, Suresh
Project Start
1997-02-01
Project End
2000-01-31
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Albany Medical College
Department
Physiology
Type
Schools of Medicine
DUNS #
City
Albany
State
NY
Country
United States
Zip Code
12208
Shinde, Arti V; Kelsh, Rhiannon; Peters, John H et al. (2015) The ?4?1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts. Matrix Biol 41:26-35
You, Ran; Zheng, Mingzhe; McKeown-Longo, Paula J (2010) The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J Biol Chem 285:36255-9
Ambesi, Anthony; McKeown-Longo, Paula J (2009) Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling. Mol Cancer Res 7:255-65
You, Ran; Klein, R Matthew; Zheng, Mingzhe et al. (2009) Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin. Matrix Biol 28:101-9
Neskey, David M; Ambesi, Anthony; Pumiglia, Kevin M et al. (2008) Endostatin and anastellin inhibit distinct aspects of the angiogenic process. J Exp Clin Cancer Res 27:61
Zheng, Mingzhe; Ambesi, Anthony; Yu, Lin et al. (2007) Quantification of fibronectin matrix assembly sites using a novel ELISA assay. Matrix Biol 26:330-3
Meckmongkol, Teerin T; Harmon, Robert; McKeown-Longo, Paula et al. (2007) The fibronectin synergy site modulates TGF-beta-dependent fibroblast contraction. Biochem Biophys Res Commun 360:709-14
Zheng, Mingzhe; McKeown-Longo, Paula J (2006) Cell adhesion regulates Ser/Thr phosphorylation and proteasomal degradation of HEF1. J Cell Sci 119:96-103
Ambesi, Anthony; Klein, R Matthew; Pumiglia, Kevin M et al. (2005) Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G(1) arrest in human microvessel endothelial cells. Cancer Res 65:148-56
Monaghan, Elizabeth; Gueorguiev, Volodia; Wilkins-Port, Cynthia et al. (2004) The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts. J Biol Chem 279:1400-7

Showing the most recent 10 out of 20 publications